Celgene Corp. has made organizational changes, effective March 1, 2016. Chairman and chief executive officer Bob Hugin will now serve as executive chairman and will continue to lead the board of directors and the strategic direction of the company. Mark Alles has been promoted to chief executive officer, and Jacqualyn Fouse, Ph.D., will be promoted to president and chief operating officer. Also, Scott Smith, president Immunology & Inflammation, will assume an expanded leadership role.   &#...